 | • レポートコード：QYR9N7553 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・転移性乳がんの治療の世界市場規模 ・主要企業別市場シェア ・転移性乳がんの治療の世界市場規模：種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法） ・転移性乳がんの治療の世界市場規模：用途別（病院、診療所、その他） ・転移性乳がんの治療のアメリカ市場規模（種類別、用途別） ・転移性乳がんの治療のヨーロッパ市場規模（種類別、用途別） ・転移性乳がんの治療の中国市場規模（種類別、用途別） ・転移性乳がんの治療の日本市場規模（種類別、用途別） ・転移性乳がんの治療の東南アジア市場規模（種類別、用途別） ・転移性乳がんの治療のインド市場規模（種類別、用途別） ・転移性乳がんの治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・転移性乳がんの治療の世界市場予測（2019年-2025年） ・転移性乳がんの治療の地域別市場予測（2019年-2025年） ... |
Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.North America and Europe are the highest revenue generating market for metastatic breast cancer treatment. As incidence rate of diagnosis is high in this region due to advanced healthcare infrastructure and awareness among people. Better reimbursement policies are also the growth factor for metastatic breast cancer treatment market. Asia-Pacific market is expected to be fastest growing market due to the large patient pool, government initiative and government funding for development of new treatments and improving healthcare conditions. Companies in this region mainly focus on generic drugs, but research & development activities are also increasing.
In 2018, the global Metastatic Breast Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Metastatic Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Breast Cancer Treatment development in United States, Europe and China.
The key players covered in this study
Roche
Novartis
Merck
Eli Lilly
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical
Bayer
Gilead Sciences
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Metastatic Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Metastatic Breast Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Metastatic Breast Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastatic Breast Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Biologic Targeted Therapy
1.4.5 Breast Surgery
1.4.6 Hormone Therapy
1.5 Market by Application
1.5.1 Global Metastatic Breast Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Metastatic Breast Cancer Treatment Market Size
2.2 Metastatic Breast Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Breast Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Metastatic Breast Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Metastatic Breast Cancer Treatment Market Size by Manufacturers
3.1.1 Global Metastatic Breast Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastatic Breast Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastatic Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Metastatic Breast Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Metastatic Breast Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Metastatic Breast Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Metastatic Breast Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Metastatic Breast Cancer Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Metastatic Breast Cancer Treatment Market Size (2014-2019)
5.2 Metastatic Breast Cancer Treatment Key Players in United States
5.3 United States Metastatic Breast Cancer Treatment Market Size by Type
5.4 United States Metastatic Breast Cancer Treatment Market Size by Application
6 Europe
6.1 Europe Metastatic Breast Cancer Treatment Market Size (2014-2019)
6.2 Metastatic Breast Cancer Treatment Key Players in Europe
6.3 Europe Metastatic Breast Cancer Treatment Market Size by Type
6.4 Europe Metastatic Breast Cancer Treatment Market Size by Application
7 China
7.1 China Metastatic Breast Cancer Treatment Market Size (2014-2019)
7.2 Metastatic Breast Cancer Treatment Key Players in China
7.3 China Metastatic Breast Cancer Treatment Market Size by Type
7.4 China Metastatic Breast Cancer Treatment Market Size by Application
8 Japan
8.1 Japan Metastatic Breast Cancer Treatment Market Size (2014-2019)
8.2 Metastatic Breast Cancer Treatment Key Players in Japan
8.3 Japan Metastatic Breast Cancer Treatment Market Size by Type
8.4 Japan Metastatic Breast Cancer Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Metastatic Breast Cancer Treatment Market Size (2014-2019)
9.2 Metastatic Breast Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Metastatic Breast Cancer Treatment Market Size by Type
9.4 Southeast Asia Metastatic Breast Cancer Treatment Market Size by Application
10 India
10.1 India Metastatic Breast Cancer Treatment Market Size (2014-2019)
10.2 Metastatic Breast Cancer Treatment Key Players in India
10.3 India Metastatic Breast Cancer Treatment Market Size by Type
10.4 India Metastatic Breast Cancer Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Metastatic Breast Cancer Treatment Market Size (2014-2019)
11.2 Metastatic Breast Cancer Treatment Key Players in Central & South America
11.3 Central & South America Metastatic Breast Cancer Treatment Market Size by Type
11.4 Central & South America Metastatic Breast Cancer Treatment Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastatic Breast Cancer Treatment Introduction
12.1.4 Roche Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastatic Breast Cancer Treatment Introduction
12.2.4 Novartis Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastatic Breast Cancer Treatment Introduction
12.3.4 Merck Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastatic Breast Cancer Treatment Introduction
12.4.4 Eli Lilly Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastatic Breast Cancer Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastatic Breast Cancer Treatment Introduction
12.6.4 Pfizer Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastatic Breast Cancer Treatment Introduction
12.7.4 AstraZeneca Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastatic Breast Cancer Treatment Introduction
12.8.4 GlaxoSmithKline Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metastatic Breast Cancer Treatment Introduction
12.9.4 Sun Pharmaceutical Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.9.5 Sun Pharmaceutical Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metastatic Breast Cancer Treatment Introduction
12.10.4 Bayer Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)
12.10.5 Bayer Recent Development
12.11 Gilead Sciences
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Metastatic Breast Cancer Treatment Key Market Segments
Table Key Players Metastatic Breast Cancer Treatment Covered
Table Global Metastatic Breast Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metastatic Breast Cancer Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Biologic Targeted Therapy Figures
Table Key Players of Biologic Targeted Therapy
Figure Breast Surgery Figures
Table Key Players of Breast Surgery
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Table Global Metastatic Breast Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Metastatic Breast Cancer Treatment Report Years Considered
Table Global Metastatic Breast Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Metastatic Breast Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Share by Regions 2014-2019
Figure Global Metastatic Breast Cancer Treatment Market Share by Regions 2014-2019
Figure Global Metastatic Breast Cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Metastatic Breast Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global Metastatic Breast Cancer Treatment Market Share by Manufacturers in 2018
Table Global Metastatic Breast Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metastatic Breast Cancer Treatment Product/Solution/Service
Table Date of Enter into Metastatic Breast Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global Metastatic Breast Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Metastatic Breast Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global Metastatic Breast Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global Metastatic Breast Cancer Treatment Revenue Market Share by Application in 2018
Figure United States Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table United States Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table United States Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Europe Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table Europe Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table Europe Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure China Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table China Metastatic Breast Cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table China Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Japan Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table Japan Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table Japan Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table Southeast Asia Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure India Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table India Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table India Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America Metastatic Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metastatic Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metastatic Breast Cancer Treatment Market Share (2018-2019)
Table Central & South America Metastatic Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metastatic Breast Cancer Treatment Market Share by Type (2014-2019)
Table Central & South America Metastatic Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metastatic Breast Cancer Treatment Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Metastatic Breast Cancer Treatment Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Bayer Company Details
Table Bayer Revenue in Metastatic Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2014-2019)
Table Bayer Recent Development
Table Gilead Sciences Company Details
Table Global Metastatic Breast Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Metastatic Breast Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global Metastatic Breast Cancer Treatment Market Size Share by Regions in 2025
Figure United States Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metastatic Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Metastatic Breast Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Metastatic Breast Cancer Treatment Market Size by Product (2019-2025)
Figure Global Metastatic Breast Cancer Treatment Market Size by Product in 2025
Table Global Metastatic Breast Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Metastatic Breast Cancer Treatment Market Size by Application (2019-2025)
Figure Global Metastatic Breast Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の転移性骨がんの薬物治療市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…- 世界の男性の乳がんの治療市場：市場規模・現状・予測 Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation.In 2018, the global Male Brea…
- 世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の転移性骨がん市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
- 世界の転移性骨疾患の治療市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Medication Treatment of Metastatic Bon…